- Home
- EH vs EVMN Comparison
EH vs EVMN Comparison
Compare EH & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EH | EVMN |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 892.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | EH | EVMN |
|---|---|---|
| Price | $12.40 | $29.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $21.85 | ★ $44.17 |
| AVG Volume (30 Days) | 471.9K | ★ 959.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.53 | $89.43 |
| Revenue Next Year | $81.37 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.23 | $13.89 |
| 52 Week High | $25.79 | $33.20 |
Technical Indicators
Market Signals| Indicator | EH | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 61.23 |
| Support Level | $11.23 | $15.80 |
| Resistance Level | $14.59 | $33.20 |
| Average True Range (ATR) | 0.43 | 3.32 |
| MACD | 0.14 | 0.17 |
| Stochastic Oscillator | 76.06 | 75.28 |
Price Performance
Historical ComparisonAbout EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.